Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and Systems
OwnerGoran Hansson, Andreas Hermanssoninventors
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to antigen specific tolerogenic antigen presenting cells presenting antigenic portions of an autoantigen and to related compositions, methods and systems.
Claims25
(canceled)
(canceled)
(canceled)
A method of preparing an antigen-specific tolerogenic antigen-presenting cell comprising:
- incubating at least one autoantigen, a fragment thereof, a derivative thereof or a precursor thereof, and an immunosuppressive cytokine with an antigen-presenting cell, such that an antigen-specific tolerogenic antigen presenting cell is produced.
(canceled)
A method of treating and/or preventing atherosclerosis, or a condition associated thereto, in an individual in need thereof, the method comprising administering to the individual an effective amount of an antigen-specific tolerogenic antigen-presenting cell adapted to present at least a portion of at least one autoantigen associated with atherosclerosis, the antigen-specific tolerogenic antigen-presenting cells being specific for the at least one autoantigen.
(canceled)
(canceled)
A pharmaceutical composition comprising an antigen-specific tolerogenic dendritic cell adapted to present of at least a portion of at least one autoantigen associated with atherosclerosis, the antigen-specific tolerogenic antigen-presenting cells being specific for the at least one autoantigen, together with a pharmaceutically acceptable vehicle.
(canceled)
Dependencies are inferred from the claim text.